🕵️ Rigel Pharmaceuticals Inc ($RIGL)
SEC insider & ownership activity, last 12 months · CIK 1034842 · every row links its SEC filing
Over the last 12 months insiders sold $306K with no open-market buying against it. Ali-Jackson Kamil sold $160K through a 10b5-1 trading plan in 2 lots (May–Jun). Blackrock, Inc. trimmed 9.9% → 7.7%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $306K (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ali-Jackson Kamil | 0 | – | 2 | $160K | Jun 22, 2026 |
| Walter H. Moos | 0 | – | 1 | $145K | Feb 20, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 7.7% | 13G | Apr 17, 2025 | filing ↗ | |
| Armistice Capital, LLC | 6.9% | 13G | May 15, 2026 | filing ↗ | |
| Steven Boyd | 6.9% | 13G | May 15, 2026 | filing ↗ | |
| Soleus GP LLC | 6.4% | 13G | Feb 11, 2025 | filing ↗ | |
| State Street Corporation | 6.0% | 13G | Feb 9, 2026 | filing ↗ | |
| Soleus Capital Master Fund, L.P. | 5.2% | 13G | May 7, 2026 | filing ↗ | |
| Soleus Capital, LLC | 5.2% | 13G | May 7, 2026 | filing ↗ | |
| Soleus Capital Group, LLC | 5.2% | 13G | May 7, 2026 | filing ↗ | |
| Soleus Capital Management, L.P. | 5.2% | 13G | May 7, 2026 | filing ↗ | |
| Soleus GP, LLC | 5.2% | 13G | May 7, 2026 | filing ↗ | |
| Guy Levy | 5.2% | 13G | May 7, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Ali-Jackson Kamil | $88K | Jun 22, 2026 | filing ↗ |
| Ali-Jackson Kamil | $73K | May 26, 2026 | filing ↗ |
| Walter H. Moos | $145K | Feb 20, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 25, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jun 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 14, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Agreement terminated (1.02) | Apr 16, 2026 | filing ↗ |
| Earnings (2.02) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 1, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Dec 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 7, 2025 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |